Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

This study has been terminated.
(not funded)
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00296972
First received: February 23, 2006
Last updated: April 19, 2007
Last verified: April 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Estimated Primary Completion Date: No date given